U S 223 150 (Lamotrigine 150 mg)
Pill with imprint U S 223 150 is Yellow, Round and has been identified as Lamotrigine 150 mg. It is supplied by Upsher-Smith Laboratories, Inc.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for U S 223 150
Lamotrigine
- Imprint
- U S 223 150
- Strength
- 150 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
- National Drug Code (NDC)
- 00245-0223
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
povidone,
sodium starch glycolate type A potato,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,535)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine (Advanced Reading)
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Other brands
- Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.